Objectives:

1. Identify the phenotype of cardiac amyloidosis in order to facilitate early diagnosis.

2. Distinguish underlying causes of cardiac amyloidosis, prognosis and treatment.

3. Learn about efficacy of standard and emerging therapies for cardiac amyloidosis.

 

Session date: 
Friday, March 31, 2017 - 12:00pm to 1:00pm
Speaker Name: 
Mathew S. Maurer, MD
Location: 
UCMC W-632
Chicago, IL 60637
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.